About Index Trending news
Analyze
Top 50 Pricing
Circassia

Circassia

Work at Circassia? Add yourself to this profile

Circassia

We're a specialty biopharmaceutical company developing novel immunotherapies for allergy including cat, grass, ragweed & house dust mite. Tweets from Lara Flynn

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series C)
$24,801,993
Venture capital (Series B)
$21,829,006
Employees

Team size

50+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Circassia makes some noise.